Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
|
|
LIFECORE BIOMEDICAL INC (LCBM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/11/2023 |
4
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (10% Owner) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Bought 1,560 convertible preferred
@ $1000, valued at
$1.6M
Bought 1,040 convertible preferred
@ $1000, valued at
$1M
Bought 650 convertible preferred
@ $1000, valued at
$650k
|
|
| 11/29/2022 |
4
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (10% Owner) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Bought 345,260 shares
@ $7.97, valued at
$2.8M
Bought 282,486 shares
@ $7.97, valued at
$2.3M
|
|
| 02/12/2009 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/10/2008 |
SC 13G/A
| BANK OF AMERICA CORP has filed a Schedule 13D for LIFECORE BIOMEDICAL, INC |
| 03/28/2008 |
4
| RUNNELLS JOHN E (Director) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 10,000 options to buy
@ $10.82, valued at
$108.2k
Disposed/sold 30,000 options to buy
@ $8.12, valued at
$243.6k
Disposed/sold 10,000 options to buy
@ $14.12, valued at
$141.2k
Disposed/sold 7,500 options to buy
@ $16.79, valued at
$125.9k
Disposed/sold 7,500 options to buy
@ $12.46, valued at
$93.5k
|
|
| 03/27/2008 |
4
| Thacker Kipling (VP of New Business Development) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 2,000 options to buy
@ $8.37, valued at
$16.7k
Disposed/sold 5,550 options to buy
@ $7.75, valued at
$43k
Disposed/sold 2,000 options to buy
@ $5.66, valued at
$11.3k
Disposed/sold 30,000 options to buy
@ $10.79, valued at
$323.7k
Disposed/sold 15,000 options to buy
@ $12.74, valued at
$191.1k
|
|
| 03/27/2008 |
4
| PERKINS RICHARD W (Director) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 10,000 options to buy
@ $10.78, valued at
$107.8k
Disposed/sold 7,500 options to buy
@ $12.46, valued at
$93.5k
|
|
| 03/27/2008 |
4
| NOEL DAVID M (CFO & VP of Finance) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 5,000 options to buy
@ $9.45, valued at
$47.3k
Disposed/sold 1,000 options to buy
@ $7.31, valued at
$7.3k
Disposed/sold 30,000 options to buy
@ $8.1, valued at
$243k
Disposed/sold 30,000 options to buy
@ $5.91, valued at
$177.3k
Disposed/sold 17,500 options to buy
@ $12.74, valued at
$223k
|
|
| 03/27/2008 |
4
| HIEBERT LARRY D (VP Operations) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 4,000 options to buy
@ $8.87, valued at
$35.5k
Disposed/sold 2,050 options to buy
@ $7.75, valued at
$15.9k
Disposed/sold 5,000 options to buy
@ $5.38, valued at
$26.9k
Disposed/sold 1,000 options to buy
@ $10.9, valued at
$10.9k
Disposed/sold 1,000 options to buy
@ $7.38, valued at
$7.4k
Disposed/sold 30,000 options to buy
@ $8.1, valued at
$243k
Disposed/sold 30,000 options to buy
@ $5.91, valued at
$177.3k
Disposed/sold 17,500 options to buy
@ $12.74, valued at
$223k
|
|
| 03/27/2008 |
4
| Hall James G (VP Technical Operations) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 625 options to buy
@ $7.19, valued at
$4.5k
Disposed/sold 750 options to buy
@ $6.66, valued at
$5k
Disposed/sold 3,750 options to buy
@ $9.63, valued at
$36.1k
Disposed/sold 2,000 options to buy
@ $10.72, valued at
$21.4k
Disposed/sold 30,000 options to buy
@ $15.91, valued at
$477.3k
Disposed/sold 15,000 options to buy
@ $12.74, valued at
$191.1k
|
|
| 03/27/2008 |
4
| Griffith Luther T (Director) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 30,000 options to buy
@ $9.63, valued at
$288.9k
Disposed/sold 7,500 options to buy
@ $12.46, valued at
$93.5k
|
|
| 03/27/2008 |
4
| GARRETT THOMAS H (Director) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 30,000 options to buy
@ $13.9375, valued at
$418.1k
Disposed/sold 8,000 options to buy
@ $7.813, valued at
$62.5k
Disposed/sold 30,000 options to buy
@ $8.12, valued at
$243.6k
Disposed/sold 10,000 options to buy
@ $14.12, valued at
$141.2k
Disposed/sold 7,500 options to buy
@ $16.79, valued at
$125.9k
Disposed/sold 7,500 options to buy
@ $12.46, valued at
$93.5k
|
|
| 03/27/2008 |
4
| EMERSON MARTIN J (Director) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 3,750 options to buy
@ $14.7, valued at
$55.1k
Disposed/sold 7,500 options to buy
@ $16.79, valued at
$125.9k
Disposed/sold 7,500 options to buy
@ $12.46, valued at
$93.5k
|
|
| 03/27/2008 |
4
| ALLINGHAM DENNIS J (President & CEO) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Disposed/sold 40,000 options to buy
@ $8.63, valued at
$345.2k
Disposed/sold 50,000 options to buy
@ $13.94, valued at
$697k
Disposed/sold 51,000 options to buy
@ $7.75, valued at
$395.3k
Disposed/sold 25,000 options to buy
@ $5.79, valued at
$144.8k
Disposed/sold 3,500 options to buy
@ $7.89, valued at
$27.6k
Disposed/sold 5,000 options to buy
@ $6.04, valued at
$30.2k
Disposed/sold 10,000 options to buy
@ $5.91, valued at
$59.1k
Disposed/sold 35,000 options to buy
@ $12.74, valued at
$445.9k
|
|
| 03/27/2008 |
8-K
| Quarterly results |
| 03/26/2008 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in Lifecore Biomedical, Inc. |
| 03/24/2008 |
4
| Thacker Kipling (VP of New Business Development) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Unknown transaction of 25,259 shares
@ $17, valued at
$429.4k
Unknown transaction of 650 shares
@ $17, valued at
$11.1k
|
|
| 03/24/2008 |
4
| PERKINS RICHARD W (Director) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Unknown transaction of 7,500 shares
@ $17, valued at
$127.5k
Unknown transaction of 6,000 shares
@ $17, valued at
$102k
Unknown transaction of 10,000 shares
@ $17, valued at
$170k
Unknown transaction of 139,000 shares
@ $17, valued at
$2.4M
|
|
| 03/24/2008 |
4
| NOEL DAVID M (CFO & VP of Finance) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Unknown transaction of 8,618 shares
@ $17, valued at
$146.5k
|
|
| 03/24/2008 |
4
| HIEBERT LARRY D (VP Operations) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Unknown transaction of 8,618 shares
@ $17, valued at
$146.5k
|
|
| 03/24/2008 |
4
| Hall James G (VP Technical Operations) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Unknown transaction of 2,356 shares
@ $17, valued at
$40.1k
|
|
| 03/24/2008 |
4
| GARRETT THOMAS H (Director) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Unknown transaction of 11,544 shares
@ $17, valued at
$196.2k
|
|
| 03/24/2008 |
4
| ALLINGHAM DENNIS J (President & CEO) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Unknown transaction of 21,600 shares
@ $17, valued at
$367.2k
|
|
| 03/24/2008 |
4
| RUNNELLS JOHN E (Director) has filed a Form 4 on LIFECORE BIOMEDICAL INC|
Txns:
| Sold 839,500 shares
@ $17, valued at
$14.3M
Sold 839,500 shares
@ $17, valued at
$14.3M
Sold 1,800 shares
@ $17, valued at
$30.6k
|
|
| 03/10/2008 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 8.2% stake in Lifecore Biomedical, Inc. |
| 02/22/2008 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 8.2% stake in Lifecore Biomedical, Inc. |
| 02/14/2008 |
SC 13G/A
| BANQUE CARNEGIE LUXEMBOURGH S A reports a 8.2% stake in * Lifecore Biomedical, Inc. |
| 02/11/2008 |
10-Q
| Quarterly Report for the period ended December 31, 2007 |
| 02/07/2008 |
SC 13G/A
| BANK OF AMERICA CORP reports a 5.8% stake in LIFECORE BIOMEDICAL, INC |
| 01/31/2008 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 01/24/2008 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 7.6% stake in Lifecore Biomedical, Inc. |
| 01/24/2008 |
SC 13G/A
| VERTICAL FUND I LP reports a 6.6% stake in LIFECORE BIOMEDICAL, INC. |
| 01/17/2008 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 7.4% stake in Lifecore Biomedical, Inc. |
| 01/15/2008 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
|
|
|